Acute exercise in elite rugby players increases the circulating level of the cardiovascular biomarker GDF-15

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 74, Issue 6, 2014, Pages 492-499

  Galliera, Emanuela ^a,b   Lombardi, Giovanni ^b   Marazzi, Monica G ^c   Grasso, Dalila ^b   Vianello, Elena ^c   Pozzoni, Roberto ^b   Banfi, Giuseppe ^b,c   Corsi Romanelli, Massimiliano M ^c,d  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Cardiovascular risk; GDF 15; Intense training; Rugby

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ERYTHROPOIETIN; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; ST2 PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GDF15 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; EXERCISE; EXERCISE INTENSITY; HEMATOLOGICAL PARAMETERS; HUMAN; NORMAL HUMAN; RUGBY; BLOOD; CARDIOVASCULAR SYSTEM; MALE; METABOLISM;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR SYSTEM; EXERCISE; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MALE;

EID: 84907044934     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2014.905697     Document Type: Article

References (44)

1. Brancaccio P, Lippi G, Maffulli N. Biochemical markers of muscular damage. Clin Chem Lab Med 2010; 48: 757-67.
2. Eijsvogels T M, Shave R, van Dijk A, Hopman MT, Thijssen DH. Exercise-induced cardiac troponin release: real-life clinical confusion. Curr Med Chem 2011; 18: 3457-61.
3. Lippi G, Schena F, Montagnana M, Salvagno GL, Banfi G, Guidi GC. Significant variation of traditional markers of liver injury after a half-marathon run. Eur J Intern Med 2011; 22: 36-8.
4. Colombini A, Corsetti R, Machado M, Graziani R, Lombardi G, Lanteri P, Banfi G. Serum creatine kinase activity and its relationship with renal function indices in professional cyclists during the Giro dItalia 3-week stage race. Clin J Sport Med 2012; 22: 408-13.
5. Patil H R, O K eefe J H, Lavie C J, Magalski A, Vogel R A, McCullough PA. Cardiovascular damage resulting from chronic excessive endurance exercise. Mo Med 2012; 109: 312-21.
6. OKeefe J H, Patil H R, Lavie C J, Magalski A, Vogel R A, McCullough PA. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc 2012; 87: 587-95.
7. Selden M A, Helzberg J H, Waeckerle J F, Browne J E, Brewer JH, Monaco ME, Tang F, O Keefe JH. Cardiometabolic abnormalities in current National Football League players. Am J Cardiol 2009; 103: 969-71.
8. Selden MA, Helzberg JH, Waeckerle JF. Early cardiovascular mortality in professional football players: fact or fiction? Am J Med 2009; 122: 811-4.
9. Helzberg JH, Camilo J, Waeckerle JF, O K eefe JH. Review of cardiometabolic risk factors among current professional football and professional baseball players. Phys Sportsmed 2010; 38: 77-83.
10. Shimano M, Ouchi N, Walsh K. Cardiokines: recent progress in elucidating the cardiac secretome. Circulation 2012; 126: 327-32.
11. Eggers KM, Kempf T, Wallentin L, Wollert KC, Lind L. Change in growth differentiation factor 15 concentrations over time independently predicts mortality in communitydwelling elderly individuals. Clin Chem 2013; 1091-8.
12. Daniels LB, Clopton P, Laughlin GA, Maisel A S, Barrett-Connor E. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study. Circulation 2012; 123: 2101-10.
13. Rohatgi A, Patel P, Das S R, Ayers C R, Khera A, Martinez-Rumayor A, Berry JD, McGuire DK, de Lemos JA. Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study. Clin Chem 2012; 58: 172-82.
14. Wang T J, Wollert KC, Larson MG. Coglianese E, McCabe EL, Cheng S, Ho JE, Fradley MG, Ghorbani A, Xanthakis V, Kempf T, Benjamin EJ, Levy D, Vasan RS, Januzzi JL. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 2012; 126: 1596-604.
15. Xu X, Li Z, Gao W. Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside. Biomarkers 2011; 16: 466-75.
16. Hohensinner P J, Niessner A, Huber K, Weyand C M, Wojta J. Inflammation and cardiac outcome. Curr Opin Infect Dis 2011; 24: 259-64.
17. Bonaterra GA, Zugel S, Thogersen J, Walter SA, Haberkorn U, Strelau J, Kinscherf R. Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent inflammatory response to vascular injury. JAm Heart Assoc 2012;e 002550.
18. Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 2011; 434: 365-81.
19. Wojtczak-Soska K, Pietrucha T, Sakowicz A, Lelonek M. Soluble ST2 protein in chronic heart failure is independent of traditional factors. Arch Med Sci 2013; 9: 21-6.
20. Banfi G, Dolci A. Preanalytical phase of sport biochemistry and haematology. JSports Med Phys Fitness 2003; 43: 223-30.
21. Banfi G, Colombini A, Lombardi G, Lubkowska A. Metabolic markers in sports medicine. Adv Clin Chem 2012; 56: 1-54.
22. Lippi G, Banfi G, Botre F, de la Torre X, De Vita F, Gomez-Cabrera MC, Maffulli N, Marchioro L, Pacifici R, Sanchis-Gomar F, Schena F, Plebani M. Laboratory medicine and sports: between Scylla and Charybdis. Clin Chem Lab Med 2012; 50: 1309-16.
23. Lippi G, Cervellin G, Banfi G, Plebani M. Cardiac troponins and physical exercise. Its time to make a point. Biochem Med (Zagreb) 2011; 21: 55-62.
24. Corsetti R, Lombardi G, Barassi A, Lanteri P, Colombini A, DEril GM, Banfi G. Cardiac indexes, cardiac damage biomarkers and energy expenditure in professional cyclists during the Giro dItalia 3-weeks stage race. Biochemia Medica 2012; 50: 237-46.
25. Hsiao E C, Koniaris LG, Zimmers-Koniaris T, Sebald SM, Huynh TV, Lee SJ. Characterization of growth-differentiation factor 15, atransforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol 2000; 20: 3742-51.
26. Zimmers T A, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 2005; 23: 543-8.
27. Zimmers T A, Jin X, Hsiao EC, Perez EA, Pierce RH, Chavin KD, Koniaris LG. Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms. JSurg Res 2006; 130: 45-51.
28. Andersson J, Jansson JH, Hellsten G, Nilsson TK, Hallmans G, Boman K. Effects of heavy endurance physical exercise on inflammatory markers in non-athletes. Atherosclerosis 2010; 209: 601-5.
29. Lombardi G, Colombini A, Lanteri P, Banfi G. Reticulocytes in sports medicine: an update. Adv Clin Chem 2013; 59: 125-53.
30. Sanchis-Gomar F, Bonaguri C, Aloe R, Pareja-Galeano H, Martinez-Bello V, Gomez-Cabrera MC, Candel J, Viña J, Lippi G. Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarkers. Transl Res 2013; 102-9.
31. Poledne R, Lorenzova A, Stavek P, Valenta Z, Hubác ek J, Such ánek P, Pitha J. Proinflammatory status, genetics and atherosclerosis. Physiol Res 2009; 58: 111-8.
32. Hingorani A D, Shah T, Casas JP, Humphries SE, Talmud PJ. C-reactive protein and coronary heart disease: predictive test or therapeutic target? Clin Chem 2009; 55: 239-55.
33. Corsetti R, Lombardi G, Lanteri P, Colombini A, Graziani R, Banfi G. Haematological and iron metabolism parameters in professional cyclists during the Giro dItalia 3-weeks stage race. Clin Chem Lab Med 2012; 50: 949-56.
34. Lira F S, Rosa J C, Lima-Silva AE, Souza H A, Caperuto EC, Seelaender MC, Damaso AR, Oyama LM, Santos RV. Sedentary subjects have higher PAI-1 and lipoproteins levels than highly trained athletes. Diabetol Metab Syndr 2010; 2-7.
35. Pihl E, Zilmer K, Kullisaar T, Kairane C, Pulges A, Zilmer M. High-sensitive C-reactive protein level and oxidative stress-related status in former athletes in relation to traditional cardiovascular risk factors. Atherosclerosis 2003; 171: 321-6.
36. Naghii MR, Aref MA, Almadadi M, Hedayati M. Effect of regular physical activity on non-lipid (novel) cardiovascular risk factors. Int J Occup Med Environ Health 2011; 24: 380-90.
37. Milani R V, Lavie CJ, Mehra M R. Reduction in C-reactive protein through cardiac rehabilitation and exercise training. JAm Coll Cardiol 2004; 43: 1056-61.
38. Demyanets S, Kaun C, Pentz R, Krychtiuk K A, Rauscher S, Pfaffenberger S, Zuckermann A, Aliabadi A, Grger M, Maurer G, Huber K, Wojta J. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. JMol Cell Cardiol 2013; 60: 16-26.
39. Bartunek J, Delrue L, Van Durme F, Muller O, Casselman F, De Wiest B, Croes R, Verstreken S, Goethals M, de Raedt H, Sarma J, Joseph L, Vanderheyden M, Weinberg EO. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. JAm Coll Cardiol 2008; 52: 2166-74.
40. Xu J, Kimball TR, Lorenz J N, Brown D A, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 2006; 342-50.
41. Nemeth E. Iron regulation and erythropoiesis. C urr Opin Hematol 2008; 98: 169-75.
42. Liu Q, Davidoff O, Niss K, Haase V H. Hypoxiainducible factor regulates hepcidin via erythropoietininduced erythropoiesis. J Clin Invest 2012; 122: 4635-44.
43. Waalen J, von Lohneysen K, Lee P, Xu X, Friedman JS. Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause. Eur J Haematol 2011; 87: 107-16.
44. BanfiG, DEril G M, Barassi A, Lippi G. N-terminal proBtype natriuretic peptide (NT-proBNP) concentrations in elite rugby players at rest and after active and passive recovery following strenuous training sessions. Clin Chem Lab Med 2008; 46: 247-9.